(WOOF) Pet Acquisition - Overview
Stock: Veterinary Care, Pet Supplies, Grooming, Training, Insurance
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 80.2% |
| Relative Tail Risk | -23.0% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.02 |
| Alpha | -40.50 |
| Character TTM | |
|---|---|
| Beta | 0.995 |
| Beta Downside | 1.309 |
| Drawdowns 3y | |
|---|---|
| Max DD | 86.70% |
| CAGR/Max DD | -0.46 |
Description: WOOF Pet Acquisition January 21, 2026
Pet Acquisition LLC (NASDAQ: WOOF) operates as Petco Health and Wellness Company, a U.S.-based provider of veterinary, grooming, training, tele-health, and pet-health-insurance services across the United States, Mexico, and Puerto Rico. The firm also sells consumables and accessories through its e-commerce platforms (petco.com, petcoach.co, petinsurancequotes.com, pupbox.com) under the WholeHearted, Reddy, and Well & Good brands. Founded in 1965 and headquartered in San Diego, the company positions itself as an integrated “health-and-wellness” ecosystem for pets and their owners.
Key recent metrics suggest the business is scaling: FY 2023 revenue reached approximately $4.1 billion, a year-over-year increase of roughly 10 % driven largely by a 15 % jump in services revenue (veterinary and tele-health). The U.S. pet-health-insurance market is expanding at a compound annual growth rate of ~12 % (2022-2027), providing a tailwind for the company’s insurance offerings. Macro-level drivers include resilient discretionary spending on pets (U.S. pet industry spending grew ~5 % YoY in 2023) and a demographic shift toward higher-income, pet-owning households, which tends to boost premium service adoption.
For a deeper, data-rich perspective on WOOF’s valuation assumptions, you might find ValueRay’s analyst framework worth a quick look.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: -2.20m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 2.71 > 1.0 |
| NWC/Revenue: -1.60% < 20% (prev -2.92%; Δ 1.31% < -1%) |
| CFO/TA 0.05 > 3% & CFO 256.5m > Net Income -2.20m |
| Net Debt (1.15b) to EBITDA (309.2m): 3.72 < 3 |
| Current Ratio: 0.91 > 1.5 & < 3 |
| Outstanding Shares: last quarter (288.2m) vs 12m ago 5.00% < -2% |
| Gross Margin: 37.73% > 18% (prev 0.37%; Δ 3736 % > 0.5%) |
| Asset Turnover: 115.2% > 50% (prev 119.7%; Δ -4.54% > 0%) |
| Interest Coverage Ratio: 0.83 > 6 (EBITDA TTM 309.2m / Interest Expense TTM 133.7m) |
Altman Z'' -0.99
| A: -0.02 (Total Current Assets 1.01b - Total Current Liabilities 1.10b) / Total Assets 5.21b |
| B: -0.22 (Retained Earnings -1.14b / Total Assets 5.21b) |
| C: 0.02 (EBIT TTM 110.4m / Avg Total Assets 5.21b) |
| D: -0.28 (Book Value of Equity -1.15b / Total Liabilities 4.05b) |
| Altman-Z'' Score: -0.99 = CCC |
Beneish M -3.49
| DSRI: 1.10 (Receivables 42.9m/40.4m, Revenue 6.00b/6.24b) |
| GMI: 0.97 (GM 37.73% / 36.73%) |
| AQI: 0.25 (AQ_t 0.11 / AQ_t-1 0.42) |
| SGI: 0.96 (Revenue 6.00b / 6.24b) |
| TATA: -0.05 (NI -2.20m - CFO 256.5m) / TA 5.21b) |
| Beneish M-Score: -3.49 (Cap -4..+1) = AA |
What is the price of WOOF shares?
Over the past week, the price has changed by -11.11%, over one month by -16.50%, over three months by -22.50% and over the past year by -25.08%.
Is WOOF a buy, sell or hold?
- StrongBuy: 0
- Buy: 2
- Hold: 8
- Sell: 2
- StrongSell: 0
What are the forecasts/targets for the WOOF price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 3.6 | 43.5% |
| Analysts Target Price | 3.6 | 43.5% |
| ValueRay Target Price | 1.8 | -28.2% |
WOOF Fundamental Data Overview February 02, 2026
P/S = 0.1261
P/B = 0.6778
Revenue TTM = 6.00b USD
EBIT TTM = 110.4m USD
EBITDA TTM = 309.2m USD
Long Term Debt = 1.58b USD (from longTermDebt, last quarter)
Short Term Debt = 351.8m USD (from shortTermDebt, last quarter)
Debt = 1.39b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.15b USD (from netDebt column, last quarter)
Enterprise Value = 1.91b USD (756.5m + Debt 1.39b - CCE 237.4m)
Interest Coverage Ratio = 0.83 (Ebit TTM 110.4m / Interest Expense TTM 133.7m)
EV/FCF = 14.71x (Enterprise Value 1.91b / FCF TTM 129.6m)
FCF Yield = 6.80% (FCF TTM 129.6m / Enterprise Value 1.91b)
FCF Margin = 2.16% (FCF TTM 129.6m / Revenue TTM 6.00b)
Net Margin = -0.04% (Net Income TTM -2.20m / Revenue TTM 6.00b)
Gross Margin = 37.73% ((Revenue TTM 6.00b - Cost of Revenue TTM 3.74b) / Revenue TTM)
Gross Margin QoQ = 38.86% (prev 39.32%)
Tobins Q-Ratio = 0.37 (Enterprise Value 1.91b / Total Assets 5.21b)
Interest Expense / Debt = 2.37% (Interest Expense 32.8m / Debt 1.39b)
Taxrate = 21.0% (US default 21%)
NOPAT = 87.2m (EBIT 110.4m * (1 - 21.00%))
Current Ratio = 0.91 (Total Current Assets 1.01b / Total Current Liabilities 1.10b)
Debt / Equity = 1.20 (Debt 1.39b / totalStockholderEquity, last quarter 1.16b)
Debt / EBITDA = 3.72 (Net Debt 1.15b / EBITDA 309.2m)
Debt / FCF = 8.87 (Net Debt 1.15b / FCF TTM 129.6m)
Total Stockholder Equity = 1.13b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.04% (Net Income -2.20m / Total Assets 5.21b)
RoE = -0.19% (Net Income TTM -2.20m / Total Stockholder Equity 1.13b)
RoCE = 4.07% (EBIT 110.4m / Capital Employed (Equity 1.13b + L.T.Debt 1.58b))
RoIC = 3.22% (NOPAT 87.2m / Invested Capital 2.71b)
WACC = 4.59% (E(756.5m)/V(2.14b) * Re(9.58%) + D(1.39b)/V(2.14b) * Rd(2.37%) * (1-Tc(0.21)))
Discount Rate = 9.58% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 3.73%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈129.6m ; Y1≈85.1m ; Y5≈38.8m
Fair Price DCF = 0.36 (EV 1.24b - Net Debt 1.15b = Equity 86.8m / Shares 243.5m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -68.45 | EPS CAGR: -31.44% | SUE: -1.64 | # QB: 0
Revenue Correlation: -6.36 | Revenue CAGR: -0.89% | SUE: -0.24 | # QB: 0
EPS next Quarter (2026-04-30): EPS=0.03 | Chg30d=+0.000 | Revisions Net=+1 | Analysts=4
EPS next Year (2027-01-31): EPS=0.21 | Chg30d=-0.001 | Revisions Net=+0 | Growth EPS=+41.7% | Growth Revenue=+0.7%